Earnings Call · Q2 FY2026·2026-08-04

Q2 26EPS +62.96%·Rev n/aQ1 26EPS +7.14%·Rev n/aQ4 25EPS -46.67%·Rev n/aQ3 25EPS +7.69%·Rev n/a⚠ consensus missing

Pacira BioSciences, Inc. PCRX

Susan Mesco — Head of Investor Relations

−10.0%1d on move date3d−9.4%5d−11.7%

Research tier

Behavioral profile computed for this call's speaker on this call.

Sign in to view the Behavioral Lean, the Behavioral Deviation Score, the speaker decomposition, and the novel forward-guidance phrases flagged on this call — each scored against the speaker's own prior-call baseline.

Behavioral data on every earnings call

Per-speaker language deviation, scored against each executive's own history. Explore more PCRX calls or request research access.

More PCRX calls Browse calls Request research access